PGR and breast cancer: DNA sequencing studies of BC genomes have revealed additional mutations and gene rearrangements involving MAGI3. A study performed on whole-exome sequences of DNA from human BC tissues identified a recurrent MAGI3-AKT3 fusion enriched in triple-negative BC lacking estrogen and progesterone receptors and ERBB2 expression [124].